CLAYTON, N.C. — Novo Nordisk, the maker of Ozempic and Wegovy, announced on Monday that it plans to add 1,000 jobs when another company manufacturing plant is built in a suburb of North Carolina’s capital to expand production of the very popular weight loss and diabetes medicines, as well as other treatments.
The announcement would mark the largest life sciences investment in state history, said Christopher Chung, CEO of the Economic Development Partnership of North Carolina, the state’s independent nonprofit recruiting organization. The average salary for the new positions will be $70,000, which is above Johnston County’s average of $50,605, the partnership said in a news release.
“The importance of this facility we’re making is ensuring that we are flexible to both produce weight-loss products but also other chronic diseases,” Novo Nordisk vice president Niels Laurbjerg Nielsen said.